Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Investor Meet Company & ProActive Investor Events Presentation

mel | 23 March 2023

Categories:

Post navigation

← 2022 Interim Results Presentation

SFX-01 in the treatment of rhabdomyosarcoma: Preclinical results in cellular models →

Copyright© 2025
ICO Reg: ZB396415
Company Number: 09246681

Website Privacy Policy and Cookie Policy
Sitemap